Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fresno, CA
NPI
1972755452
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
7085 N Chestnut Ave Ste 101
Fresno, CA, 93720
Phone (559) 323-9236
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
595 services
Medicare patients, 2024
355
Average age 73
Drug cost, 2024
$1.7M
3,074 prescriptions
Company payments, 2025
$298
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Varsha Babu was code 99214 (office e&m - established), 296 times for 203 patients. In total Varsha Babu billed 595 services in 14 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 296 | 203 | $93.98 | $28K |
| 76536 Ultrasound - Nonspecific | Office | 108 | 105 | $85.86 | $9,273 |
| 99213 Office E&M - Established | Office | 74 | 68 | $65.53 | $4,849 |
| 95251 Test - Miscellaneous | Office | 41 | 25 | $26.71 | $1,095 |
| 99204 Office E&M - New | Office | 26 | 26 | $130.54 | $3,394 |
| 99222 Hospital E&M - Initial | Facility | 24 | 23 | $93.35 | $2,240 |
| 83036 Blood Count | Office | 11 | 11 | $9.52 | $105 |
By year: 2022 $57K for 748 services; 2023 $50K for 613 services; 2024 $50K for 595 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 11 | 11 | $9.52 | $105 |
Medicare prescription drug claims, 2024
In 2024, the drug Varsha Babu prescribed most often to Medicare patients was Levothyroxine Sodium, with 455 prescriptions and refills. In total Varsha Babu wrote 3,074 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 455 | 1,302 | 136 | $6,627 |
| Ozempic Semaglutide | 273 | 464 | 76 | $416K |
| Metformin Hcl Generic | 134 | 348 | 42 | $1,124 |
| Synthroid Levothyroxine Sodium | 129 | 379 | 38 | $16K |
| Trulicity Dulaglutide | 103 | 184 | 27 | $173K |
| Pioglitazone Hcl Generic | 102 | 292 | 37 | $1,868 |
| Metformin Hcl Er Metformin Hcl | 98 | 269 | 35 | $1,519 |
| Mounjaro Tirzepatide | 86 | 119 | 20 | $120K |
| Methimazole Generic | 86 | 225 | 29 | $1,007 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 82 | 200 | 29 | $8,552 |
| Jardiance Empagliflozin | 81 | 223 | 34 | $122K |
| Farxiga Dapagliflozin Propanediol | 70 | 160 | 20 | $85K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 63 | 152 | 23 | $11K |
| Atorvastatin Calcium Generic | 48 | 141 | 18 | $615 |
| Alendronate Sodium Generic | 45 | 126 | 14 | $304 |
Brand drugs: 1,482 claims; generic drugs: 1,405 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Varsha Babu $298 ($298 in general payments such as food, travel and fees) from 3 companies. The largest payer was Neurocrine BioSciences, Inc. with $103.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.